Ticker: ALAB

Astera Labs (ALAB)

Semiconductors Technology Semiconductors

Price 289.79

Reco Buy Potential 70 Risk 56 Updated 2026-09-10

Official website

Forecast impact

neutral

Target +16.5% target fill 85.9%

Reaction D5 -10.49% · D10 -5.24%

Impact Potential 0 · Risk 0 valid until 2026-09-16

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Astera Labs is a technology company specializing in semiconductor solutions for data centers and high-performance computing. Its core products include advanced optical interconnects and integrated circuits designed to enhance data transmission speeds and efficiency. The company primarily generates revenue from sales of its semiconductor products, targeting sectors such as cloud computing and artificial intelligence.

Investment Profile

The investment profile of Astera Labs is more aligned with growth investors, given its focus on innovative semiconductor technologies and strong revenue growth. The absence of dividends suggests a reinvestment strategy aimed at expansion. The stock may appeal to those looking for long-term capital appreciation rather than immediate income.

Category: Semiconductors Sector: Technology Industry: Semiconductors Investment style: Growth Horizon: Medium-term Company type: Niche Player

Fundamental metrics (experimental) Updated: 2026-09-08

EPS (TTM) — earnings per share for the last 12 months, $: 2.17
Revenue QoQ — quarter-over-quarter revenue growth: 27.3%
EPS surprise: 15.8%
20d volatility: 3.6%

AI recommendation changes

Date	Before	After	Reason
2026-09-06	Hold	Buy	Strong revenue growth and positive EPS surprise signal potential.
2026-08-20	Buy	Hold	Strong growth but high volatility and uncertainty present.
2026-08-08	Hold	Buy	Strong momentum and positive earnings surprise support growth outlook.
2026-08-06	Buy	Hold	Mixed performance; high risk with uncertain momentum.
2026-08-01	Sell	Buy	Strong momentum and positive earnings growth signal opportunity.
2026-07-25	Hold	Sell	Negative momentum and high risk outweigh potential upside.
2026-07-21	Sell	Hold	Strong growth but recent volatility raises concerns.
2026-07-17	Buy	Sell	Negative momentum and high risk outweigh potential growth.
2026-06-03	Hold	Buy	Strong momentum and positive earnings growth signal opportunity.
2026-05-08	—	Hold	Strong growth but recent volatility raises concerns.
2026-05-08	Hold	Hold	Компания показывает положительный тренд в долгосрочной перспективе с ростом выручки и хорошими показателями EPS, однако недавнее падение цены акций вызывает опасения.
2026-05-07	Buy	Hold	Компания показывает сильный рост выручки и положительные результаты по сравнению с ожиданиями, что свидетельствует о высоком потенциале. Низкий риск также поддерживается стабильными финансовыми показателями.
2026-04-21	Hold	Buy	Компания показывает сильный рост выручки и положительную динамику акций за последние 20 дней. Умеренный риск связан с недавней волатильностью на рынке.
2026-04-09	Sell	Hold	Компания показывает положительную динамику в краткосрочной перспективе, однако долгосрочные показатели остаются негативными, что указывает на неопределенность в будущем.
2026-03-27	Sell	Hold	Компания демонстрирует значительное снижение цены акций за последние месяцы, что указывает на высокие риски. При этом EPS и рост выручки не компенсируют падение, что делает инвестиции в текущий момент нецелесообразными.
2026-03-06	—	Sell	Компания демонстрирует значительное снижение цены на протяжении последних месяцев, что указывает на высокие риски. Отсутствие данных о прибыли и выручке также вызывает сомнения в ее финансовом состоянии.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-08-17	Northland Securities	Rating Upgraded	— → 350	321.61
2026-08-05	Roth Capital	Target Raised	275 → 450	337.48999
2026-08-05	RBC Capital	Target Raised	425 → 500	361.67
2026-08-05	UBS	Target Raised	400 → 425	361.67
2026-08-05	Needham	Target Raised	— → 425	361.67
2026-08-05	Jefferies	Target Raised	270 → 450	361.67
2026-08-03	Morgan Stanley	Target Raised	240 → 335	311.23
2026-07-31	Susquehanna	Target Raised	230 → 275	299.69
2026-07-20	Barclays	Target Raised	200 → 325	303.62
2026-06-29	UBS	Target Raised	205 → 400	405.66501
2026-06-24	Stifel Nicolaus	Target Raised	260 → 460	397.02
2026-05-19	Evercore ISI	Target Raised	215 → 297	215.58
2026-05-07	Barclays	Target Raised	165 → 200	213.91
2026-05-06	Needham	Target Raised	220 → 260	205.715
2026-05-06	Susquehanna	Target Raised	155 → 230	209.19
2026-05-06	Roth Capital	Target Raised	225 → 275	205.66
2026-05-06	RBC Capital	Target Raised	250 → 270	206.5
2026-05-06	Stifel Nicolaus	Target Raised	236 → 260	215.69
2026-05-06	Morgan Stanley	Target Raised	210 → 240	215.69
2026-05-06	Jefferies	Target Raised	225 → 270	215.69
2026-05-01	Stifel Nicolaus	Target Raised	200 → 236	194.74
2026-05-01	Redburn Partners	Update	— → 153	194.74
2026-04-21	RBC Capital	Target Raised	225 → 250	175.8
2026-04-21	UBS	Update	— → 180	175.8
2026-01-15	Barclays	Target Raised	155 → 165	172.14
2026-01-14	RBC Capital	Update	— → 225	172.14
2025-12-09	Northland Securities	Target Raised	175 → 195	167.63
2025-12-03	Morgan Stanley	Update	— → 210	142.94
2025-11-17	Northland Securities	Rating Upgraded	— → 175	142.8781
2025-11-05	Stifel Nicolaus	Target Raised	185 → 200	173.33
2025-11-05	Needham	Target Raised	— → 220	179.31
2025-10-17	Stifel Nicolaus	Target Raised	174 → 185	163.55

News Page 1 of 1

Investment Strategy Insights: Analyzing Growth Stocks Amid Market Volatility

06/09/2026, 11:33 AM investing research ai software Astera Labs (ALAB)

The article discusses the differences between horse racing and stock investing, emphasizing the flexibility investors have to adjust their strategies in real-time based on market conditions. It highlights the recent selloff in growth stocks and outlines potential portfolio adjustments, particularly increasing exposure to technology stocks like Astera Labs, which is positioned for significant growth in the AI infrastructure sector.